When did Exagen Inc. report Q2 2025 earnings?

Exagen Inc. (XGN) reported Q2 2025 earnings on July 29, 2025 before market open.

What were Exagen Inc.'s Q2 2025 revenue and EPS?

Exagen Inc. reported revenue of $17.2M and eps of $-0.18 for Q2 2025.

Did Exagen Inc. beat estimates in Q2 2025?

Revenue beat the consensus estimate of $16.9M by $300.8K. EPS beat the consensus estimate of $-0.18 by $0.00.

How did Exagen Inc.'s Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 14.2% from $15.1M a year earlier and eps declined 12.5% from $-0.16.

Where can I find Exagen Inc.'s Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001274737-25-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.

Exagen Inc. XGN Q2 2025 earnings

Reported July 29, 2025 · Before market open

Revenue$17.2MBeat by $300.8K

EPS-$0.18In line

Revenue estimate$16.9M

EPS estimate-$0.18

Next report

Aug 4, 2026 (In 6 days)

Revenue estimate$17.8M

EPS estimate-$0.19

Financials

Q2 2025

Income statement

See full

Revenue$17.2M+14.2%

Gross profit$10.4M+14.8%

Operating income-$2.6M-1.7%

Net income-$4.4M-49.7%

EPS (diluted)-$0.21-31.2%

Balance sheet

See full

Cash & equivalents$30.2M+22.5%

Total debt$25.2M+5.6%

Total equity$21.0M+19.6%

Total assets$58.8M+19.2%

Cash flow

See full

Operating cash flow-$2.9M-18.9%

CapEx$209.0K+53.7%

Free cash flow-$3.1M-20.8%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$154.34M+373%

Enterprise value$149.31M+369%

P/S2.6×+2.0×

Profitability

See full

Gross margin59.4%+0.3pp

Operating margin-23.9%-3.0pp

Net margin-28.8%-1.5pp

FCF margin-27.5%—

Returns & leverage

See full

Return on equity-87.9%+30.4pp

Debt / equity1.2×-0.2×

Current ratio5×+0.6×

Segments

By segment

See full

Reportable Segment$17.2M+14.2%

Versus estimates

Revenue

Q1 2026$17.3MBeat by $897.4K Q4 2025$16.6MBeat by $60.7K Q3 2025$17.2MBeat by $708.3K

Q2 2025$17.2MBeat by $300.8K

Q1 2025$15.5MBeat by $944.0K Q4 2024$13.7MMiss by $912.5K

Diluted EPS

Q1 2026-$0.17Beat by $0.07 Q4 2025-$0.20In line Q3 2025-$0.19Miss by $0.06

Q2 2025-$0.18In line

Q1 2025-$0.20In line Q4 2024-$0.20Beat by $0.07

Ask the moment Exagen Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Exagen Inc. report Q2 2025 earnings?: Exagen Inc. (XGN) reported Q2 2025 earnings on July 29, 2025 before market open.
What were Exagen Inc.'s Q2 2025 revenue and EPS?: Exagen Inc. reported revenue of $17.2M and eps of $-0.18 for Q2 2025.
Did Exagen Inc. beat estimates in Q2 2025?: Revenue beat the consensus estimate of $16.9M by $300.8K. EPS beat the consensus estimate of $-0.18 by $0.00.
How did Exagen Inc.'s Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 14.2% from $15.1M a year earlier and eps declined 12.5% from $-0.16.
Where can I find Exagen Inc.'s Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001274737-25-000063) directly on SEC EDGAR. The filing index links above go to sec.gov.